Funder
Institutional Program for Scientific Initiation Scholarships
Subject
Cancer Research,Infectious Diseases,Virology
Reference29 articles.
1. Phase 3, multicenter open-label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naive, HCV GT1b-infected patients, with non-severe fibrosis;Abergel;Liver Int.,2020
2. Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil;Aguiar;Clin. Res. Hepatol. Gatroenterol.,2019
3. New direct-acting antivirals combination of the treatment of chronic hepatitis C;Asselah;Liver Int.,2011
4. Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow;Asselah;Liver Int.,2012
5. Eliminating hepatitis C within low income countries – the need to cure genotypes 4,5,6;Asselah;J. Hepatol.,2017
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献